working with the Editorial Advisory Board and authors, to present therapeutic data and findings which are critical to those health care practitioners who directly influence the drug therapy decision-making process. Issues important to clinical practice and rational drug therapy will be aired in DICP. I feel that these directions for the journal are still part of the vast living stream of professional evolution encouraged and expounded by Dr. Donald Francke.
Clinical practitioners and educators wishing to contribute to any of the established DICP columns should contact the column editor, preferably before beginning to write. Early guidance can thus be obtained and duplication of effort avoided. Whenever Pharm.D. students or residents make a contribution, appropriate coauthorship by experienced faculty should be included. Comments and suggestions are welcomed from all sources in the coming months. transition in symbols from the mortar and pestle to the bowl of Hygeia. This symbolic change could be interpreted to mean that the pharmacist no longer relies on his ability to "mix and make" drugs but rather on his knowledge of drugs and drug therapy in serving his patients. Although the symbolic change is apparently complete, many practitioners in the profession still cling to the last vestige of the past: the packaging of drugs. In referring to the packaging of drugs, I include the tasks of counting and pouring, both of which should be relegated to the mortar and pestle era. It seems absurd for pharmacists to continue to perform these acts when modern technology permits the state-of-the-art to advance into a new era. As long as some pharmacists continue to spend a significant portion of their time involved in manual activities, they will never find time to develop a viable clinical practice.
The technological availability of unit-of-use packaging makes it possible for the pharmacist to completely disengage himself from packaging activities. As soon as these packages are made widely available by the pharmaceutical industry, then pharmacists will have sufficient time to fully utilize their clinical skills. The problem that prevents more rapid introduction of unit-of-use packages is not in the technical development but rather in the acceptance of the concept by physicians, pharmacists and patients. Until pharmacists exert some initiative and promote the concept, it will not be universally adopted. Like the early days of unit dose, pharmacists must also work with industry representatives and encourage them, for otherwise they will have little incentive.
Pharmacists in favor of unit-of-use packaging are getting support from the Food and Drug Administration. In January 1979, the FDA conducted a conference on this subject for the benefit of the industry and pharmacy practitioners. Specific objectives of the conference were:
1. Define unit-of-use packaging as it is and as it is becoming.
2. Become acquainted with the European experience in unit-of-use packaging.
3. Identify technical problems of the drug manufacturer, the pharmacist and the wholesaler.
4. Identify problems of acceptance by the health care providers.
5. Identify economic factors affecting the drug manufacturer, the pharmacist, the wholesaler and the consumer.
6. Determine desirability of defining drug coverage and unit-of-use package quantities.
Several speakers at this meeting were from European countries because "original pack" dispensing, as it is referred to abroad, has been accepted there for several years. Other speakers included representatives from medical practice, pharmacy practice, industry and the United States Pharmacopeial Convention. Within this issue of the journal is reproduced Dr. William M. Heller's presentation from the FDA meeting. Dr. Heller's proposal for a nongovernmental alternative to unit-of-use packaging merits serious consideration. 
Unit-of-Use Package
A definition: The unit-of-use dispensing package for the United States can be defined as a package carrying the manufacturer's recommended course of treatment (or, if for a chronic disease, a 30-day supply) and labeled with a tripart label: two parts of which are identical and one of which remains on the dispensed container and indicates the name of the drug, strength, manufacturer's lot number, the National Drug Code (NDC) number, expiration date, and the number of units in the container. A similar but self-adhesive label is attached to the prescription order of the prescriber for proof positive that an error has or has not been made. The third part is the well-known conventional label, found on all legend drug containers, that is removed by the dispenser at the time of dispensing and replaced by the pharmacy's usual label. (Ref.
Archambault, G. F.: An Evolution in Drug Dispensing, Hosp. Form. 14:70-79 (Jan.) 1979.) 
